Chemistry: molecular biology and microbiology – Vector – per se
Patent
1997-03-21
2000-10-03
Crouch, Deborah
Chemistry: molecular biology and microbiology
Vector, per se
435455, C12N 1500, C12N 500
Patent
active
061271705
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is in the field of methods for the transfer of genetic information, e.g., foreign DNA, into target cells, especially eukaryotic cells. In particular, the present invention relates to nonviral gene carriers comprising multifunctional molecular conjugates which include, inter alia, lipopolyamines of a particular configuration, a component which promotes endosome disruption, and a receptor specific binding component. The present application is related to U.S. Ser. No. 08/314,060 filed Sep. 28, 1994 and entitled "Multifunctional molecular complexes for gene transfer to cells" which is incorporated herein by reference.
Heretofore, viral vectors of various types have been successfully utilized for the insertion of selected foreign genetic information into a target cell, and in the case of eukaryotic cells, for incorporation of that genetic information into the genome of the cell. These viral vector systems have relied upon the molecular machinery of the virus, evolved over time to surmount the significant problems facing a virus in attempting to invade, i.e., infect a cell. Despite the efficiency of such viral vectors, however, there has been continued concern regarding the safety of using viruses, particularly from the standpoint of undesired side effects. Thus, there has been an ongoing effort to develop non-viral gene delivery systems that are as efficient as viral vectors, but with an improved safety profile.
Nonviral vectors or carriers, of the type with which the present invention is concerned, will thus have to overcome the same obstacles as a viral vector. The problems faced by such carriers include persistence in the biophase of the organism for a sufficient time to reach the target cell; recognition of the target cell and means for mediating transport of the genetic material through the cell membrane and into the cytoplasm of the cell; avoidance of degradation within the cell by the reticuloendothelial system; and transport to and through the nuclear membrane into the nucleus of the cell where transcription of the genetic material can take place.
It is to overcoming the problems described above that the present invention is addressed; and since the problems are several and different, the present invention comprises a multifunctional complex, i.e., a molecular conjugate of various ligands intended to surmount specific obstacles.
The ultimate usefulness of gene transfer techniques is of enormous potential benefit in a number of areas. The transfer of genetic material into cells is the basis of a number of processes now widely accepted in the areas of molecular biology, gene therapy and genetic immunization. Transfer of the genetic information encoded in DNA to cells where it expresses identified individual proteins, has permitted investigation of the function of such proteins on a cellular level, and of the underlying cell physiology. Genetic material has also been transferred into cells to introduce proteins that are absent due to an inherent genetic flaw in the cell that expresses an inactive protein or else prevents expression of the protein altogether. The transfer of genetic material into cells can be used to prevent the expression of proteins in those cells through the well-known antisense effect of complementary DNA or RNA strands.
Exogenous, i.e., foreign genetic material can permit cells to synthesize significant amounts of proteins that are not available by other means in practical economic terms. These proteins of interest can be grown in a variety of host cells such as yeast, bacterial or mammalian cells. Genetic material can also be used to provide protective immune responses in vivo by injection of DNA that encodes immunogenic proteins, i.e., ones that can stimulate the desired immune response. The in vivo introduction of exogenous genetic material into cells also has potential utility in applications for the alleviation, treatment or prevention of metabolic, tumoral or infectious disorders by the same mechanisms e
REFERENCES:
patent: 5108921 (1992-04-01), Low et al.
patent: 5166320 (1992-11-01), Wu et al.
patent: 5171678 (1992-12-01), Behr et al.
patent: 5283185 (1994-02-01), Epand et al.
patent: 5614503 (1997-03-01), Chaudhary et al.
patent: 5650096 (1997-07-01), Harris et al.
patent: 5719131 (1998-02-01), Harris et al.
patent: 5747471 (1998-05-01), Siegel et al.
patent: 5767099 (1998-06-01), Harris et al.
patent: 5783565 (1998-07-01), Siegel et al.
patent: 5840710 (1998-11-01), Lee et al.
patent: 5910487 (1999-06-01), Yew et al.
patent: 5912239 (1999-06-01), Siegel et al.
patent: 5925628 (1999-07-01), Lee et al.
patent: 5935936 (1999-08-01), Fasbender et al.
patent: 5942634 (1999-08-01), Siegel et al.
patent: 5948767 (1999-09-01), Scheule et al.
patent: 5981273 (1999-11-01), Curiel et al.
Berman et al (1988) J. Infect. Dis. 157, 897-902.
Connelly, C. et al., "Polyamines Eliminate an Extreme Size Bias against Transformation of Large Yeast Artificial Chromosome DNA", Genomics, 1991, 10, 10-16.
Jones, J. and Risser, "Cell Fusion Induced by the Murine Leukemia Virus Envelope Glycoprotein", J. of Virology, 1993, 67(1), 67-74.
Kono, K. et al., "Fusion Activity of an Amphiphilic Polypeptide Having Acidic Amino Acid Residues: Generation of Fusion Activity by .alpha.-Helix Formation and Charge Neutralization", Biochimica et Biophysica Acta 1993, 1164, 81-90.
Lear, J. and DeGrado, "Membrane Binding and Conformational Properties of Peptides Representing the NH.sub.2 Terminus of Influenza HA-2", The J. of Biol. Chem., 1987, 262(14), 6500-6505.
Midoux, P. et al., "Specific Gene Transfer Mediated by Lactosylated Poly-L-Lysine into Hepatome Cells", Nucleic Acids Res., 1993, 21(4), 871-878.
Neiva, J. et al., "Interaction of the HIV-1 Fusion Peptide with Phospholipid Vesicles: Different Structural Requirements for Fusion and Leakage", Biochemistry, 1994, 33, 3201-3209.
Schlegel, R. and Wade, "A Synthetic Peptide Corresponding to the NH.sub.2 Terminus of Vesicular Stomatitis Virus Glycoprotein is a pH-Dependent Hemolysin", J. Biol. Chem., 1984, 259(8), 4691-4694.
Soukchareun, S. et al., "Preparation and Characterization of Antisense Oligonucleotide-Peptide Hybrids Containing Viral Fusion Peptides", Bioconjugate Chem., 1995, 6, 43-53.
White, J., "Membrane Fusion", Science, 1992, 258, 917-924.
Yeagle, P. et al., "Effects of the "Fusion Peptide" From Measles Virus on the Structure of N-Methyl Dioleoylphosphatidylethanolamine Membranes and their Fusion with Sendai Virus", Biochimica et Biophysica Acta, 1991, 1065, 49-53.
Atanasiu et al., "Virologie--Production de tumneurs chez le Hamster par inoculation d'acide desoxyribonucleique extrait de cultures de tissus infectees par le virus du polyome", Academie des Sciences (Paris), 1962, 254, 4228-4230.
Barthel et al., "Laboratory Methods: Gene Transfer Optimization with Liposperimine-Coated DNA", DNA and Cell Biol., 1993, 12, 553-560.
Behr et al., "Efficient Gene Transfer Into Mammalian Primary Endocrine Cells with Lipopolyamine-Caoted DNA", Proc. Nat. Acad. Sci. USA, 1989, 86, 6982-6986.
Bennett et al., "Cationic Lipids Enhance Cellular Uptake and Activity of Phosphorothioate Antisense Oligonucleotides", Mol. Pharm., 1992, 41, 1023-1033.
Bodmer and Dean, "Carrier Potential of GLycoproteins", Meth. Enzymol., 1985, 112, 298-306.
Bonfils et al., "Drug Targeting: Synthesis and Endocytosis of Oligonucleotide-Neoglycoprotein Conjugates", Bioconj. Chem., 1992, 3, 277-284.
Bonfils et al., "Uptake by Macrophages of A Biotinylated Oligo-.alpha.-Deoxythymidylate by Using Mannosylated Strepatvidin", Nucl. Acids Res., 1992, 20, 4621-4629.
Chaudhary et al., "A Rapid Method of Cloning Functional Variable-Region Antibody Genes in Escherichia coli as Single-Chain Immunotoxins", Proc. Natl. Acad. Sci. USA, 1990, 87, 1066-1070.
Chu et al., "Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture", Pharm. Res., 1990, 7, 824-854.
Citro et al., "Inhibition of Leukemia Cell Proliferation by Receptor-Mediated Uptake of c-myb Antisense Oli
American Home Products Corporation
Crouch Deborah
LandOfFree
Multifunctional complexes for gene transfer into cells comprisin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multifunctional complexes for gene transfer into cells comprisin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multifunctional complexes for gene transfer into cells comprisin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-194271